Inside, between rows of incubators and microscopes, Beth Shapiro and her team are attempting a feat straight out of science ...
Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...
16 天on MSN
Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.
Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.
Many remarkable animal species have gone extinct due to human activities, climate change, and habitat destruction. The Spix’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果